Skip to content
TrialScanner

NCT01953926

Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

Phase 2TerminatedPBYILead

Registry record

Lead sponsor
Puma Biotechnology, Inc.
Conditions
Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
Primary completion
Jan 2, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01953926 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01953926: Basket Study of Neratinib in... | TrialScanner